Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Nitraria Retusa Infusion in Significantly Reducing Clozapine-induced Metabolic Side Effects in Patients With Treatment-resistant Schizophrenia: A Pre-Experimental Pilot Study

NCT07817069 is registered in ClinicalTrials.gov with Faculty of Medicine, Sousse as lead sponsor.

NCT NCT07817069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Nitraria Retusa Infusion in Significantly Reducing Clozapine-induced Metabolic Side Effects in Patients With Treatment-resistant Schizophrenia: A Pre-Experimental Pilot Study
Lead sponsor
Faculty of Medicine, Sousse
Phase
Not applicable
Overall status
Recruiting
Start date
January 3, 2026
Completion date
December 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal obesity, obesity & overweight, treatment resistant schizophrenia